Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Rethinking Lead Optimization:

Adopting New Synthetic Biology Tools to Accelerate Development Timelines

White paper: Read how advances in synthetic biology automation are enabling researchers to to streamline antibody discovery and optimization workflows.

In this white paper, you’ll learn how:

  • Antibody development programs can overcome process bottlenecks and realize substantial process optimization gains by leveraging continuing advances in synthetic biology automation.
  • Comprehensive automated workflow solutions enable antibody therapeutic scientists to leverage synthetic biology for both lead discovery and optimization, at a throughput, speed and scale that keeps pace with the current demands of development timelines.

Telesis Bio’s BioXp® automation platform streamlines screening and optimization workflows of antibody candidates by enabling high-throughput synthesis and cloning as well as generation of antibody variant libraries overnight, and at the push of a button.

Contact us

The expertise of our scientists, engineers and supporting teams are at your service! Submit the form below and/or call us at 858.526.3080.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

By clicking Submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.